[Clinical experience with ceftizoxime suppositories in bacterial infections in children]. 1985

T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka

A clinical trial of ceftizoxime suppositories (CZX-S) was performed to evaluate the therapeutic effectiveness in children with bacterial infection. The subjects were 10 children comprising 4 with pneumonia, 3 with lacunar tonsillitis, 2 with pharyngitis, and 1 with UTI. They were given 1 suppository containing either 125 mg or 250 mg of CZX 2 to 4 times a day. The daily per kg body weight dose ranged from 17.1 to 60.0 mg. The result was "markedly effective" in 3, "effective" in 6, and "failure" was recorded in 1. Bacteriologically, successful eradication of causative organisms was confirmed in all the 4 children who underwent the test. No clinical side effects were observed. The only laboratory test abnormality recorded in a single patient was eosinophilia, which was not definitely ascribable to CZX-S. In conclusion, CZX-S have proved to be a clinically safe and effective antibiotic preparation in infantile infection, even in children whose treatment with conventional antibiotics is associated with difficulties.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka
October 1985, The Japanese journal of antibiotics,
T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka
October 1985, The Japanese journal of antibiotics,
T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka
October 1985, The Japanese journal of antibiotics,
T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka
October 1985, The Japanese journal of antibiotics,
T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka
October 1985, The Japanese journal of antibiotics,
T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka
October 1985, The Japanese journal of antibiotics,
T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka
October 1985, The Japanese journal of antibiotics,
T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka
October 1985, The Japanese journal of antibiotics,
T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka
October 1985, The Japanese journal of antibiotics,
T Hosoda, and M Masuda, and T Ichioka, and M Miyao, and K Kamada, and Y Yuasa, and Y Uyama, and H Tanaka
October 1985, The Japanese journal of antibiotics,
Copied contents to your clipboard!